General Information of the Compound
Compound ID
CP0032193
Compound Name
4-[3-[[4-(1-methylpyrazol-4-yl)phenyl]methyl]-2H-indazol-5-yl]morpholine
    Show/Hide
Structure
Formula
C22H23N5O
Molecular Weight
373.46
Canonical SMILES
Cn1cc(cn1)-c1ccc(Cc2n[nH]c3ccc(cc23)N2CCOCC2)cc1
    Show/Hide
InChI
InChI=1S/C22H23N5O/c1-26-15-18(14-23-26)17-4-2-16(3-5-17)12-22-20-13-19(6-7-21(20)24-25-22)27-8-10-28-11-9-27/h2-7,13-15H,8-12H2,1H3,(H,24,25)
    Show/Hide
InChIKey
UETJKJCLDAZMNX-UHFFFAOYSA-N
Physicochemical Property
logP
3.3908
Rotatable Bonds
4
Heavy Atom Count
28
Polar Areas
58.97
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
5
Complexity
28

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 127034165
ChEMBL ID
CHEMBL3774744
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01975, Cyclin-dependent kinase 8
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 > 30000 nM
   TI
   LI
   LO
   TS